THOMAS HAN: Open Payments
NPI 1184348617 · ALHAMBRA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$770 in 20 payments from 7 companies in 2025. Trend: 2023 $698 · 2024 $1,003 · 2025 $770
Food & beverage: $770
| Company | Payments | Amount |
|---|---|---|
| Eisai Inc. | 3 | $276 |
| Teva Pharmaceuticals USA, Inc. | 8 | $255 |
| MDD US Operations, LLC | 4 | $94 |
| Amneal Pharmaceuticals LLC | 2 | $50 |
| Merz Pharmaceuticals, LLC | 1 | $41 |
| Lundbeck LLC | 1 | $29 |
| ABBVIE INC. | 1 | $25 |
Products named: Leqembi, AUSTEDO XR, CREXONT, INBRIJA, VYEPTI, UBRELVY, Gocovri.
Industry payments across CA — which companies pay providers there.
